Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy

被引：5

作者：

Musset, L

Ghillani, P

Lunel, F

Cacoub, P

Cresta, P

Frangeul, L

Rosenheim, M

Preudhomme, JL

机构：

[1] GRP HOSP PITIE SALPETRIERE,VIROL LAB,F-75651 PARIS 13,FRANCE

[2] GRP HOSP PITIE SALPETRIERE,DEPT HEPATOGASTROENTEROL,F-75651 PARIS 13,FRANCE

[3] GRP HOSP PITIE SALPETRIERE,DEPT INTERNAL MED,F-75651 PARIS 13,FRANCE

[4] GRP HOSP PITIE SALPETRIERE,PUBL HLTH UNIT,F-75651 PARIS 13,FRANCE

[5] UNIV POITIERS HOSP,LAB IMMUNOL & IMMUNOPATHOL,CNRS URA 1172,POITIERS,FRANCE

来源：

IMMUNOLOGY LETTERS | 1997年 / 55卷 / 01期

关键词：

hepatitis C virus; IgG subclass; interferon-alpha;

D O I：

10.1016/S0165-2478(96)02681-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Serum IgG1 levels are selectively increased in patients with chronic hepatitis C virus (HCV) infection. In 15 patients who received interferon (IFN)-alpha therapy, serum levels of immunoglobulin classes and IgG subclasses were measured during treatment and after it was discontinued. In spite of important individual variations, mean IgG, IgG1, IgA and IgM levels decreased during therapy and tended to return to pre-treatment levels afterwards, with no detectable correlation with clinical and biological parameters. These results suggest an effect of IFN-alpha on in vivo immunoglobulin production, in HCV carriers. (C) 1997 Elsevier Science B.V.

引用

页码：41 / 45

页数：5

共 50 条

[31] PROGNOSTIC IMPORTANCE OF HEPATITIS-C VIRUS GENOTYPES FOR THE RESPONSIVENESS TO INTERFERON-ALPHA
BERG, T
KONIG, V
KUTHER, S
HEUFT, HG
WITTMANN, G
LOBECK, H
HOPF, U
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1995, 33 (08): : 426 - 430
[32] Renal failure associated with hepatitis C virus infection - Improvement in renal function after treatment with interferon-alpha
Moses, PL
Krawitt, EL
Aziz, W
Corwin, HL
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (02) : 443 - 446
[33] Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: Relief by cisapride
Nishibayashi, H
Kanayama, S
Shinomura, Y
Kawata, S
Matsuzawa, Y
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (06) : 547 - 551
[34] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
Carmen Sorina Martin
Luminita Nicoleta Ionescu
Carmen Gabriela Barbu
Anca Elena Sirbu
Ioana Maria Lambrescu
Ioana Smarandita Lacau
Doina Ruxandra Dimulescu
Simona Vasilica Fica
BMC Endocrine Disorders, 14
[35] Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C
Gonzalez, German
Castro, Fernando P.
Berho, Mariana
Petras, Robert
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (05) : 1490 - 1493
[36] Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C
Niewold, TB
Swedler, WI
CLINICAL RHEUMATOLOGY, 2005, 24 (02) : 178 - 181
[37] Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C
Martin, Carmen Sorina
Ionescu, Luminita Nicoleta
Barbu, Carmen Gabriela
Sirbu, Anca Elena
Lambrescu, Ioana Maria
Lacau, Ioana Smarandita
Dimulescu, Doina Ruxandra
Fica, Simona Vasilica
BMC ENDOCRINE DISORDERS, 2014, 14
[38] Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C
German Gonzalez
Fernando P. Castro
Mariana Berho
Robert Petras
Digestive Diseases and Sciences, 2010, 55 : 1490 - 1493
[39] Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C
Timothy B. Niewold
William I. Swedler
Clinical Rheumatology, 2005, 24 : 178 - 181
[40] LICHEN PLANUS DUE TO INTERFERON ALPHA PLUS RIBAVIRIN THERAPY IN A CIRRHOTIC PATIENT WITH HEPATITIS C VIRUS INFECTION
Li, Zhengxiao
Zhang, Yanfei
Tu, Chen
Jia, Xiaoli
Xiao, Shengxiang
Ji, Fanpu
JOURNAL OF DERMATOLOGY, 2014, 41 : 22 - 22

← 1 2 3 4 5 →